David Lawrence, Chief Financial Officer at ACORDA THERAPEUTICS INC (ACOR), sold 12,000 shares at $34.16 ($410K) on 2010-03-10, disclosed to the SEC on 2010-03-12.
Seasonal sale ($410k) by Chief Financial Officer — this insider has traded ACOR in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ACOR | SELL | 2018-12-06 | $102K | — | Filing → |
| ACOR | SELL | 2018-06-13 | $208K | — | Filing → |
| ACOR | SELL | 2018-06-11 | $1.3M | — | Filing → |